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Objective: The aortic media lesion is a key pathologic feature in thoracic aortic dis-
section. To identify key proteins in aortic media lesions that may contribute to its path-
ogenesis, we performed proteomic studies to find differentially expressed proteins in
the media from diseased and normal thoracic aorta.
Methods:Ascending aortic segments were obtained from patients with thoracic aortic
dissection (n 5 8) and age-matched normal donors (n 5 6). The differentially ex-
pressed proteins of their media tissues were analyzed by 2-dimensional electrophore-
sis and mass spectrometry, and verified by Western blotting. Oxidative stress was
measured by functional assays in a larger sample size (15 patients and 10 controls).
Results: Image analysis of the protein profiles from 2-dimensional gels revealed 126
differentially expressed proteins, of which 26 were identified by mass spectrometry.
Among them, extracellular superoxide dismutase, an enzyme involved in oxidative
stress, was selected for further studies. Western blotting showed that extracellular
superoxide dismutase expression was more than 50% lower in patient samples than
in controls (P , .001). Superoxide dismutase activity was consistently decreased
(P , .001) and lipid peroxidation was increased (P 5 .019) in patient media
homogenates compared with that in controls.
Conclusion: Our results indicate that protein expression profiles in the aortic media
from thoracic aortic dissection differ significantly from that of controls, which may
provide important insights into the disease mechanisms. This study also suggests
that increased oxidative stress may play an important role in the disease.
T
horacic aortic dissection (TAD) is one of the most catastrophic aortic diseases.
It is characterized by the separation of thoracic aortic wall layers by extralumi-
nal blood that usually enters the vessel wall via an intimal tear.1 Mechanisms
weakening the aortic wall can induce aortic dilatation, aneurysm formation, and even
rupture.1 The development of endovascular techniques has improved the diagnosis
and treatment of TAD. To date, however, the mortality associated with aortic rupture
remains high. Many patients with TAD die of aortic rupture before reaching hospitals.
Thus, it is important to develop strategies to prevent this catastrophic disease. Many
studies have been performed to understand the pathogenesis of TAD. Most of them
focus on the genetic heterogeneity, clinical pathology, and hemodynamics of
TAD,2,3 which have provided important insights into the disease mechanisms.
Proteomics using 2-dimensional gel electrophoresis (2-DE) and mass spectrometry
(MS)4 has recently been applied to study cancer5 and cardiovascular diseases.6
Comparative proteomics (ie, diseased vs normal tissue) has been used to study
atherosclerosis, including coronary and carotid atherosclerotic plaques and the
smooth muscle cell (SMC) secretome.7-9 McGregor and colleagues10 presented a
protein profile map of human saphenous vein medial smooth muscle by 2-DE and
identified 129 differentially expressed proteins. To date, comparative proteomic
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2-DE 5 2-dimensional gel electrophoresis
EC-SOD 5 extracellular superoxide dismutase
HSP 5 heat shock protein
MDA 5 malondialdehyde
MS 5 mass spectrometry
NA 5 normal thoracic aorta
SMC 5 smooth muscle cell
SOD 5 superoxide dismutase
TAD 5 thoracic aortic dissection
profiles of the aorta from patients with TAD have not been
reported. Such data will help to identify key proteins
involved in TAD and elucidate their functions in the disease.
In this study, we initiated a proteomic analysis of aortic
tissues from patients with TAD. Because cellular composi-
tion in the aortic wall is heterogeneous, a proteomic analysis
of the entire aortic wall will be technically challenging. For
instance, intimal atherosclerotic lesions are present in most
aortas from patients with TAD, whereas such lesions are
less common in normal thoracic aortas (NAs), making com-
parative studies difficult. To circumvent this problem, we
focused on the aortic media, which is more homogenous
in its cellular composition.
By using 2-DE andMS, we produced a first map of human
thoracic aortic media protein profiles and analyzed differen-
tially expressed proteins between the TAD and NA groups. A
total of 126 differentially expressed proteins were identified,
of which 26 proteins were analyzed by MS. One of them,




Aortic samples. The study was approved by the ethics commit-
tee of our hospital. All patients gave informed consent. Ascending
aorta segments were collected from patients with TAD undergoing
surgical repair (8 male, mean age: 47.56 6.9 years). NAs were from
organ donors (6 male, mean age: 39.5 6 7.2 years). No significant
difference in age was found between the TAD and NA groups
(P. .05). A detailed description of aortic samples is supplemented
online (Table E1). All samples used in this study were prepared in
parallel on the basis of a published method.10 Briefly, media tissues
were cut into small pieces and stored at280C until protein extrac-
tion. Some tissues were preserved by paraffin imbedding for immu-
nohistochemistry validation using monoclonal antibody specific for
SMC marker (alpha smooth muscle actin) and endothelial cell
marker (CD-31). Hematoxylin and eosin and Victoria blue staining
for elastic and collagen fibers were done for all tissue samples using
standard procedures.
Preparation of tissue samples. Tissue samples were prepared
according to the methods described by Weekes and colleagues11
and McGregor and colleagues.10 Frozen aortic tissues (10 mg)
were ground using a grinding tube with a matching pestle in an66 The Journal of Thoracic and Cardiovascular Surgery c Julyiced bath. Resulting powders were homogenized in 100 mL lysis
buffer (9 mol/L urea, 4% CHAPS, 65 mmol/L dithiothreitol, and
1 mmol/L phenylmethylsulfonyl fluoride) at 4C for 5 minutes
and then centrifuged at 4C at 14,000 rpm for 1 hour. The
supernatant was collected, and protein concentrations were
determined using a modified method described by Bradford.12
Supernatant samples were divided into 50-mL aliquots and stored
at 280C.
Two-dimensional gel electrophoresis. 2-DE was performed
according to the methods described by Weekes and colleagues11
and Yu and colleagues.13 The details of these methods are provided
in supplemented documents online (Appendix E1).
Image analysis. Images of stained gels were acquired using
a scanner (GS-800 densitometry, Bio-Rad, Richmond, Calif) and
analyzed with PDQuest 7.2.0 2-dimensional image analysis soft-
ware (Bio-Rad).14 Spot densities were determined following nor-
malization based on total spot volumes on the gel. Protein spots
from different gels were matched. Protein spots that had significant
changes in densities (P , .05) in a consistent direction (increase or
decrease) were considered to be different.
Mass spectrometry. In-gel tryptic digestion and MS identifica-
tion were carried out according to published methods.13,14 The
peptide mass spectrum for each sample was obtained with matrix-
assisted laser desorption/ionization time-of-flight/time-of-flight
MS (Bruker, Daltonics Autoflex Billerica, MA). The obtained pep-
tide masses were searched against the National Center for Biotech-
nology Information protein database using the Mascot program
(Matrix Science, Boston, Mass).
Western Blotting
Western blotting analysis of aortic protein extracts was performed to
validate EC-SOD expression with standard procedures. A rabbit
anti–EC-SOD polyclonal antibody (Alpha Diagnostic International,
San Antonio, TX), and horseradish peroxidase-labeled secondary
antibody (Santa Cruz Biochemicals, Santa Cruz, Calif) were used
in these studies.
Assays for Oxidative Stress
Superoxide dismutase (SOD) activity, lipid peroxidation, and cat-
alase activity in aortic media tissues were determined. In addition
to the samples used in 2-DE, we included additional samples from
other patients to increase sample size and to confirm our findings in
independent patients. There was no significant difference in age
between the TAD group (13 men and 2 women, mean age: 47.4
6 9.2 years) and NA group (9 men and 1 woman, mean age:
40.9 6 6.7 years) (P . .05). A detailed description of these sam-
ples is supplemented online (Table E1). SOD activity in aortic me-
dia homogenates was assayed on the basis of a published method
that measures the inhibitory rate of xanthine oxidase-mediated
reduction of cytochrome c (pH 7.4).15 Cyanide (3 mmol/L) was
used to distinguish between the cyanide-sensitive isozymes
Cu/Zn-SOD and EC-SOD from the cyanide-resistant manganese-
SOD. Lipid peroxidation was assayed by measuring the levels of
malondialdehyde (MDA) reacted with thiobarbituric acid at 535
nm.16 MDA concentrations were expressed as nanomoles per mil-
liliter. Catalase activity was determined by monitoring the break-
down of hydrogen peroxide catalyzed by the catalase enzyme,17
and the results were expressed as units per milligram of protein.2008
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Statistical analyses were performed using the Statistical Package for
the Social Sciences 15.0 (SPSS Inc, Chicago, IL.). Continuous and
categoric variables were compared by t test and chi-square/Fisher
exact test, respectively. Descriptions of continuous variables were
presented as mean 6 standard deviation.
Results
Histopathology of Thoracic Aortic Dissection
The ascending aortas from patients with TAD were enlarged
and dissected. In most samples examined, large amounts of
blood clots were found in false lumens (Figure 1, A). Micro-
scopic examination of hematoxylin and eosin- and Victoria
blue-stained tissues (Figure 1, B and C) showed that the dis-
section spread along the laminate of the media between themiddle and outer third layers. The aortic wall specimen had
elastic fiber loss and fragmentation in the media. Medial tis-
sue identity was confirmed by positive immunostaining of an
anti-alpha smooth muscle actin antibody (Figure 1, D) and
negative staining of an anti-CD31 antibody (data not shown).
Differential Protein Expression between Thoracic
Aortic Dissection and Normal Thoracic Arteries
Protein profiles were generated by 2-DE. The match rate for
protein spots in the same group was 86.7%6 7.1% in the NA
group and 82.1% 6 7.5% in the TAD group, indicating
a good reproducibility under our experimental conditions.
The overall 2-DE profiles of the aortic media from the
TAD and NA samples were similar (Figure 2, A and B).Figure 1. Histopathology of TAD. An image of an ascending aorta from a patient with TAD showing an enlarged and
dissected aorta with large amounts of blood clots in the false lumen (A). Hematoxylin and eosin staining of TAD
aortic tissue showing the dissected layer in the middle media (B). Fragmentation and rigidity of elastic fiber
(blue) in TAD by Victoria blue staining (C). Verification of aortic media by immunostaining of alpha smooth muscle
actin (brown) in the media (D).
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from a normal control (A) and patient with TAD (B). Protein spots identified by MS were marked with numbers.
Enlarged pictures of silver-stained gels highlight the significant differences between samples from patients and
controls (C).Analysis using PDQuest software showed that the total
numbers of effective spots in the 2-DE gels were 2123.3 6
366.8 for the NA group and 2049.5 6 403.7 for the TAD
group (P . .05).
By gel matching, 126 differentially expressed protein
spots (P , .05) were found between the TAD and NA
groups. Twenty-six spots with clear and relatively high ex-
pression, scattering locations, and significantly differential
expression (most of them . 5-fold) between the 2 groups
were selected for MS identification. These spots may be
used as markers for future 2-DE studies. Proteins identified
by MS were marked with numbers (Figure 2) and listed in
Table 1. Significant differences are highlighted in the en-
larged pictures of silver-stained gels (Figure 2, C). The pep-
tide sequences identified using matrix-assisted laser
desorption/ionization time-of-flight/time-of-flight-MS are
listed in Table E2. Peptide mass fingerprinting and the tan-
dem mass spectrophotometry spectrum of a representative
spot (number 15) are shown in Figure 3.
As shown in Table 1, several cytoskeletal proteins, such as
smooth muscle 22-alpha, destrin, alpha-actinin-2–associated
LIM protein, and skeletal muscle LIM-protein FHL1, were
identified. Other proteins, including EC-SOD, osteoglycin,
and heat shock protein (HSP) 27, were found to have de-
creased expression levels in TAD samples. Other identified
proteins included transferrin, hemoglobin chain, fibrin, and
serum albumin, some of which may be from residual blood
clots in the TAD tissues.68 The Journal of Thoracic and Cardiovascular Surgery c JulyWestern Blotting Verification of Extracellular
Superoxide Dismutase Expression
Among the differentially expressed proteins identified, one
protein, EC-SOD, is of particular interest because of its
role in oxidative stress. We used Western blotting to verify
its expression in the tissue samples used in the 2-DE experi-
ments. EC-SOD protein was found in samples from both NA
and TAD groups (Figure 4, A). The level of protein expres-
sion was significantly lower in the TAD group than in the
NA group (0.43 6 0.04 vs 1.01 6 0.03 relative amount of
protein, respectively; P , .001) (Figure 4, B).
Oxidative Stress Increases in Thoracic Aortic
Dissection
EC-SOD is an important antioxidative enzyme in the vessel
wall. The reduced EC-SOD expression level suggests an im-
paired antioxidative mechanism in the aortic wall in patients
with TAD. We next examined oxidative stress markers by
functional assays in a larger sample size. Consistently, the
level of MDA in aortic media homogenates was significantly
increased in the TAD group (n 5 15) compared with that in
the NA group (n5 10) (2.336 0.31 nmol/mL vs 1.306 0.18
nmol/mL, respectively; P 5 .019) (Figure 5, A). No signifi-
cant differences in catalase activity and manganese-SOD ac-
tivity were found between the 2 groups (P. .05, Figure 5, B
andC). Total SOD activity was lower in aortic media homog-
enates from the TAD group than in the NA group (4.15 6
0.24 vs 6.56 6 0.29 U/mg, respectively; P , .001).2008
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1 Destrin (actin depolymerizing factor) gij55661046 8.84/15.7 8.15/17.8 17/126*
2 Smooth muscle 22-alpha/transgelin gij62205326 8.87/22.6 6.78/20.8 59/145
3 Smooth muscle 22-alpha/transgelin gij179032 8.78/22.6 7.15/21.7 19/114*
4 Smooth muscle 22-alpha/transgelin gij62205326 8.87/22.6 7.08/18.5 43/75
5 Smooth muscle 22-alpha/transgelin gij179032 8.78/22.6 7.09/17.8 8/60*
6 Chain A, domain 3 from human serum albumin gij71042087 8.22/23.3 7.02/16.3 24/76
7 Chain D, hemoglobin (deoxy) mutant gij999567 6.70/15.9 7.13/15.9 75/148
8 Chain D, hemoglobin (deoxy) mutant gij999567 6.70/15.9 7.17/15.9 75/147
9 Chain C, hemoglobin thionville alpha chain mutant gij493852 7.82/15.4 8.25/15.1 21/94*
10 Chain C, hemoglobin thionville alpha chain mutant gij493852 7.82/15.4 8.87/15.8 21/144*
11 Actin, alpha 2, smooth muscle, aorta gij55957587 5.31/16.9 4.98/17.7 26/117*
12 Alpha actin gij178027 5.23/42.5 5.26/31.5 10/148*
13 Heat shock protein 27 gij662841 7.83/22.4 5.68/25.6 17/110*
14 Heat shock protein 27 gij662841 7.83/22.4 6.25/25.6 17/110*
15 Superoxide dismutase 3, extracellular gij4507151 6.14/26.3 6.32/28.3 17/69*
16 Superoxide dismutase 3, extracellular gij4507151 6.14/26.3 6.54/28.3 17/60*
17 Osteoglycin gij33150528 5.33/34.2 5.30/33.6 19/142*
18 Osteoglycin gij33150528 5.33/34.2 5.33/33.6 11/134*
19 Skeletal muscle LIM-protein FHL1 gij2853224 8.72/33.8 8.54/34.6 20/52
20 Alpha-actinin-2–associated LIM protein gij3138924 8.38/34.7 8.06/36.7 23/168*
21 Beta fibrinogen precursor gij182430 8.31/55.5 5.56/52.3 6/56*
22 Fibrin beta gij223002 7.95/51.4 6.12/50.1 12/112*
23 Similar to human albumin gij763431 5.69/53.4 5.68/58.3 17/55
24 Serum albumin gij55669910 5.57/67.2 5.83/70.2 30/162
25 Serum albumin gij55669910 5.57/67.2 5.84/70.2 52/259
26 Transferrin gij37747855 6.97/79.3 7.14/79.1 14/270*
pI/MM, Isoelectric point/molecular mass; NCBI, National Center for Biotechnology Information. *Verification by tandem mass spectrophotometry (matrix-
assisted laser desorption/ionization time-of-flight/time-of-flight mass spectrometry).Moreover, the activity of cyanide-sensitive isozymes SOD
(Cu/Zn-SOD plus EC-SOD) was significantly decreased in
the TAD group compared with that in the NA group (5.69
6 0.29 U/mg vs 3.32 6 0.21 U/mg, respectively; P ,
.001) (Figure 5, C).
Discussion
In this study, we applied 2-DE and MS techniques to obtain
protein expression profiles of the ascending aorta media from
patients with TAD and normal controls. We found a total of
126 differentially expressed proteins between these 2 groups,
of which 26 were identified by MS. Our results indicate that
protein profiles of aortic media were significantly altered in
TAD, which may contribute to the pathogenesis of the
disease.
Oxidative stress plays a key role in the pathogenesis of
vascular diseases.18 EC-SOD is a major form of SOD in
the vessel wall and represents an important enzymatic antiox-
idant defense system.15 Decreased EC-SOD expression has
been found to be associated with increased vascular oxidative
stress.18 We found that EC-SOD expression was markedlyThe Journal of Threduced in the media samples from patients with TAD in
this proteomic study (Figure 2, spots 15 and 16). Therefore,
we selected this protein for further validation studies.
We examined EC-SOD protein expression in aortic media
tissues by Western blotting and confirmed its lower expres-
sion in TAD samples (Figure 4). This finding was supported
in additional functional assays. We showed that total SOD
activity and Cu/Zn-SOD activities decreased markedly in
TAD samples compared with that in normal controls (Fig-
ure 5, C). In addition, the MDA level, an indicator of lipid
peroxidation,16 was increased significantly in TAD tissues
(Figure 5, A). Our results indicate that oxidative stress is sig-
nificantly increased in the aortic wall in patients with TAD.
The data suggest that increased oxidative stress may be an
important contributing factor in the pathogenesis of TAD.
However, we cannot rule out at this time that the observed
EC-SOC expression change is partially due to the inflamma-
tory reaction in the TAD tissue. It is equally possible that the
aorta in patients with TAD reacts poorly to existing oxidative
stress because of the decreased expression of free radical
scavengers, such as SOD, which may eventually lead tooracic and Cardiovascular Surgery c Volume 136, Number 1 69
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CDFigure 3. Peptide mass fingerprinting and tandem mass spectrophotometry spectrum of spot 15. Peptide mass fin-
gerprinting spectrum of spot 15 by matrix-assisted laser desorption/ionization time-of-flight-MS (A). Three peptides
(red) were selected for tandemmass spectrophotometry identification. Tandemmass spectrophotometry spectrum of
spot 15 (B) was from 1418 m/z (A, gray circle). Spot 15 was identified to be EC-SOD.detrimental changes in its structure. These possibilities need
to be tested in future experiments.
In addition to EC-SOD, we found other proteins that were
differentially expressed between the TAD and NA groups.
Among them, destrin (spot 1) is a member of the actin depo-
Figure 4. Western blotting verification for EC-SOD protein expres-
sion. EC-SOD and the internal control protein (beta-actin) were
detected in aortic samples from the NA and TAD groups (A). Quan-
titative analysis of EC-SOD expression in TAD (n5 8) and NA (n5
6) groups (B). *P < .05. EC-SOD, Extracellular superoxide dismu-
tase; NA, normal thoracic aorta; TAD, thoracic aortic dissection.70 The Journal of Thoracic and Cardiovascular Surgery c Jullymerizing factor family and regulates actin cytoskeleton in
various eukaryotes.19 Smooth muscle 22-alpha, represented
by spots 2 to 5 for its isoforms or modifications of the protein,
is a SMC-specific actin binding protein that is considered as
an earliest contractile marker of differentiated SMCs.20 Feil
and colleagues21 showed that smooth muscle 22 alpha–mod-
ulated vascular SMCs phenotype during vascular remodel-
ing. Skeletal muscle LIM-protein FHL1 (spot 19) and ALP
(spot 20) are involved in cytoskeletal integrity22 and reorga-
nization.23 The altered expression of these cytoskeletal pro-
teins in the aortic media of patients with TAD indicates
that cytoskeletal reorganization may be impaired in the aorta,
suggesting a possible mechanism of defective aortic remod-
eling in the disease.
We also found 2 isoforms of HSP27 (spots 13 and 14) in
the aortic media of patients with TAD. These proteins are
similar to 2 distinct HSP27 isoforms identified in human ve-
nous media by McGregor and colleagues.10 HSP27 is likely
to play a role in the actin filament remodeling during SMC
migration and contractions.24 It has been suggested that
HSP27 increases the resistance against oxidative stress-in-
duced actin fragmentation.25 Therefore, HSP27 may play
a role in the remodeling process of TAD, partially by regulat-
ing SMC functions.
Another interesting finding was the decreased osteoglycin
protein (spots 17 and 18) in patients with TAD. Previous
studies on osteoglycin expression in rat SMCs and carotid
arteries, as well as human coronary arteries, have suggested
that this protein is a new marker for differentiated SMCsy 2008
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CDFigure 5. MDA levels, catalase activity,
and SOD activity in aortic samples. In-
creased MDA in the TAD group com-
pared with that in the NA group (A).
Catalase activity was lower in the TAD
group than in the NA group, but the dif-
ference was not statistically significant
(B). Total SOD activity and activities
of cyanide-sensitive SOD (Cu/Zn-SOD
plus EC-SOD) were also decreased in
the TAD group compared with the NA
group (C). *P < .05. MDA, Malondialde-
hyde; NA, normal thoracic aorta; TAD,
thoracic aortic dissection; EC-SOD,
extracellular superoxide dismutase;
Mn-SOD, manganese-superoxide dis-
mutase; SOD, superoxide dismutase.and may be an essential component of the normal vascular
matrix.26 The decreased osteoglycin expression in patients
with TAD suggests that SMC phenotypic change and vascu-
lar matrix remodeling may occur in the aortic media of TAD.
Conclusions
Our proteomic analysis of the aortic media from the TAD and
NA groups identified a number of differentially expressed
proteins. In particular, we found expression pattern changes
in EC-SOD, osteoglycin, and some cytoskeletal proteins in
tissues from patients with TAD. These new findings suggest
that increased oxidative stress and impaired vessel wall re-
modeling may be possible molecular mechanisms in the path-
ogenesis of TAD. We recognize that the patient sample size
in this study was small and that protein spots identified by
computer-based statistical algorithm need to be verified ex-
perimentally. At this time, it is unclear whether the protein
expression changes observed are the cause or effect of the
dissection. Thus, additional mechanistic studies are needed
to define the role of the identified proteins in TAD. Our
results should encourage further characterization of the
differentially expressed proteins, which may lead to new hy-
potheses. Together, a better understanding of the molecular
mechanisms underlying TAD should help to design more ef-
fective strategies to diagnose and treat this life-threatening
disease.
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CDAppendix E1
The first dimension immobilized pH gradients Dalt (IPG-Dalt) 2-dimensional gel electrophoresis was run on an IPGphor isoelectric focusing
(IEF) system. IEF was performed using 130-mm, immobilized, nonlinear pH gradient strips (IPG DryStrips; GE Healthcare, Amershan-
Biosciences, Piscataway, NJ) of pH 3 to 10. A total protein load of 100 mg per IPG DryStrip was mixed with a rehydration solution containing
8mol/L urea, 2%CHAPS, 0.5% IPG buffer, pH 3–10 L, 18mmol/L dithiothreitol (DTT), and a trace of bromophenol blue, to a total volume of
250 mL, and rehydrated overnight in a re-swelling tray. After rehydration for 12 hours, IEF was conducted automatically at low voltages (500–
1000V) during the first 2 hours and then continued with a maximum setting of 8000V to reach a total of 40 kVh for analytic runs or 65 to 70
kVh for preparative runs at 20C. After IEF separation, the strips were equilibrated in 6 mol/L urea containing 30% (v/v) glycerol, 2% (w/v)
sodium dodecylsulfate, and 0.01% (w/v) bromphenol blue, with the addition of 1% (w/v) DTT for 15 minutes, followed by the same buffer
without DTT but with the addition of 2.5% (w/v) iodoacetamide for 15 minutes. Sodium dodecylsulfate–polyacrylamide gel electrophoresis
was performed using 1-mm–thick, 12% T, 2.6% C separating polyacrylamide gels without a stacking gel using the Hoefer SE 600 (Amer-
sham). The second dimension was carried out at a constant current of 10 mA/gel for 15 minutes and then switched to 30 mA/gel until the
bromphenol dye front had reached the bottom of the gels. After electrophoresis, analytic 2-dimensional gels were fixed for a minimum of
1 hour in a methanol:acetic acid:water solution (4:1:5 v/v/v). Analytic 2-dimensional protein profiles were visualized by silver staining using
the OWL Silver Staining Kit (Insight Biotechnology Ltd, Wembley, UK), and preparative 2-dimensional gels were stained using Coomassie
Brilliant Blue R-350 stain for subsequent mass spectrometry analysis.The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 1 72.e1
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CDTABLE E1. Clinical characteristics of groups with normal thoracic arteries and thoracic aortic dissection
NA* (n 5 6) TAD* (n 5 8) NAy (n 5 10) TADy (n 5 15)
Age (y) 39.5 6 7.2 47.5 6 6.9 40.9 6 6.7 47.4 6 9.2
Male/female 6/0 8/0 13/2 9/1
Maximal diameter (cm) 2.48 6 0.29 5.56 6 1.17 2.36 6 0.29 5.55 6 1.11
Atherosclerosis 2 (33.3%) 7 (87.5%) 3 (33.3%) 14 (93.3%)
Hypertension 0 (0.0%) 7 (87.5%) 0 (0.0%) 13 (86.6%)
Bicuspid aortic valve 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Marfan syndrome 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
DeBakey type I aortic dissection — 8 (100%) — 15 (100%)
NA, Normal thoracic aorta; TAD, thoracic aortic dissection. *Sample groups for proteomic analysis. ySample groups for oxidative stress assay (including the
samples in *groups).72.e2 The Journal of Thoracic and Cardiovascular Surgery c July 2008
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CDTABLE E2. Protein sequences identified by matrix-assisted laser desorption/ionization time-of-flight and time-of-flight
mass spectrometry
N Protein identity Peptide matches Sequences Sequence coverage (%)
1 Destrin 2 R.YALYDASFETK.E 17
K.HFVGMLPEKDCR.Y
3 Smooth muscle 22-alpha/transgelin 3 R.LGFQVWLK.N 19
K.TDMFQTVDLFEGK.D
R.LVEWIIVQCGPDVGRPDR.G
11 Actin, alpha 2, smooth muscle, aorta 3 R.AVFPSIVGRPR.H 26
K.IWHHSFYNELR.V
R.VAPEEHPTLLTEAPLNPK.A
13 Heat shock protein 27 3 R.RVPFSLLR.G 17
R.LFDQAFGLPR.L
R.VSLDVNHFAPDELTVK.T
15 Superoxide dismutase 3, extracellular 3 K.VTEIWQEVMQR.R 17
R.AGLAASLAGPHSIVGR.A
R.LACCVVGVCGPGLWER.Q




20 Alpha-actinin-2–associated LIM protein 4 R.LSGGIDFNQPLVITR.I 23
K.INLESEPQEFKPIGTAHNR.R
R.GLIPSSPQNEPTASVPPESDVYR.M
K.GYFFIEGELYCETHAR.AThe Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 1 72.e3
